Literature DB >> 25051217

Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?

Abdul R Hakeem1, Gabriele Marangoni, Stephen J Chapman, Richard S Young, Amit Nair, Ernest L Hidalgo, Giles J Toogood, Judy I Wyatt, Peter A Lodge, K R Prasad.   

Abstract

BACKGROUND: Lymph node (LN) status is an important predictor of survival following resection of perihilar cholangiocarcinoma (PHCCA). Controversies still exist with regard to the prognostic value of optimum extent of lymphadenectomy, total number of nodes removed, LN ratio (LNR) and neutrophil-lymphocyte ratio (NLR) on overall survival (OS) and disease-free survival (DFS) following PHCCA resection.
METHODS: From 1994 to 2010, 84 PHCCAs were resected; 78 are included in this analysis. Kaplan-Meier survival curves were studied using log-rank statistics to assess which variables affected OS and DFS. The variables that showed statistical significance (P<0.05) on Kaplan-Meier univariate analysis were subjected to multivariate analysis using Cox proportional hazards model.
RESULTS: Five-year OS for node-positive status (n=45) was 10%, whereas node-negative (n=33) OS was 41% (P<0.001). Similarly, 5-year DFS was worse in the node-positive group (8%) than in the node-negative group (36%, P=0.001). There was no difference in 5-year OS (31 vs. 12%, P=0.135) and DFS (22 vs. 16%, P=0.518) between those with regional lymphadenectomy and those who underwent regional plus para-aortic lymphadenectomy, respectively. On univariate analysis, patients with 20 or more LNs removed had worse 5-year OS (0%) when compared with those with less than 20 LNs removed (29%, P=0.047). Moderate/poor tumour differentiation, distant metastasis and LN involvement were independent predictors of OS. Positive LNR had no effect on OS. Vascular invasion and an LNR of at least 0.37 were independent predictors of DFS. NLR had no effect on OS and DFS.
CONCLUSION: Extended lymphadenectomy patients (≥20 LNs) had worse OS when compared with those with more limited (<20 LNs) resection. An LNR of at least 0.37 is an independent predictor of DFS.

Entities:  

Mesh:

Year:  2014        PMID: 25051217     DOI: 10.1097/MEG.0000000000000162

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  23 in total

1.  Tumor grade and sex should influence the utilization of portal lymphadenectomy for early stage intrahepatic cholangiocarcinoma.

Authors:  Sean P Martin; Samantha Ruff; Laurence P Diggs; Justin Drake; Reed I Ayabe; Zachary J Brown; Michael M Wach; Seth M Steinberg; Jeremy L Davis; Jonathan M Hernandez
Journal:  HPB (Oxford)       Date:  2018-08-20       Impact factor: 3.647

2.  Defining Facility Volume Threshold for Optimization of Short- and Long-Term Outcomes in Patients Undergoing Resection of Perihilar Cholangiocarcinoma.

Authors:  Mohamedraed Elshami; Jonathan J Hue; Fasih Ali Ahmed; Hanna Kakish; Richard S Hoehn; Luke D Rothermel; Jeffrey M Hardacre; John B Ammori; Jordan M Winter; Lee M Ocuin
Journal:  J Gastrointest Surg       Date:  2022-09-22       Impact factor: 3.267

3.  Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study.

Authors:  Zhimin Yu; Qinghua Liu; Hao Liao; Juanyi Shi; Zhenyu Zhou; Yongcong Yan; Junyao Xu; Chuanchao He; Kai Mao; Jianlong Zhang; Jie Wang; Zhiyu Xiao
Journal:  J Gastrointest Oncol       Date:  2022-04

4.  Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma.

Authors:  Hai-Jie Hu; Yan-Wen Jin; Rong-Xing Zhou; Wen-Jie Ma; Qin Yang; Jun-Ke Wang; Fei Liu; Nan-Sheng Cheng; Fu-Yu Li
Journal:  J Gastrointest Surg       Date:  2018-08-03       Impact factor: 3.452

5.  Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma.

Authors:  Kai Mao; Jieqiong Liu; Jian Sun; Jianlong Zhang; Jie Chen; Timothy M Pawlik; Lisa K Jacobs; Zhiyu Xiao; Jie Wang
Journal:  J Gastroenterol Hepatol       Date:  2016-02       Impact factor: 4.029

6.  Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium.

Authors:  Eliza W Beal; Lai Wei; Cecilia G Ethun; Sylvester M Black; Mary Dillhoff; Ahmed Salem; Sharon M Weber; Thuy Tran; George Poultsides; Andre Y Son; Ioannis Hatzaras; Linda Jin; Ryan C Fields; Stefan Buettner; Timothy M Pawlik; Charles Scoggins; Robert C G Martin; Chelsea A Isom; Kamron Idrees; Harveshp D Mogal; Perry Shen; Shishir K Maithel; Carl R Schmidt
Journal:  HPB (Oxford)       Date:  2016-09-24       Impact factor: 3.647

7.  The Prognostic Importance of the Number of Metastatic Lymph Nodes for Patients Undergoing Curative Resection Followed by Adjuvant Chemoradiotherapy for Extrahepatic Bile Duct Cancer.

Authors:  Byoung Hyuck Kim; Kyubo Kim; Eui Kyu Chie; Jeanny Kwon; Jin-Young Jang; Sun Whe Kim; Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Sung W Ha
Journal:  J Gastrointest Surg       Date:  2015-08-04       Impact factor: 3.452

8.  Evaluation of Four Lymph Node Classifications for the Prediction of Survival in Hilar Cholangiocarcinoma.

Authors:  Zhi-Peng Liu; Qing-Yi Zhang; Wei-Yue Chen; Yu-Yan Huang; Yan-Qi Zhang; Yi Gong; Yan Jiang; Jie Bai; Zhi-Yu Chen; Hai-Su Dai
Journal:  J Gastrointest Surg       Date:  2022-01-01       Impact factor: 3.267

Review 9.  The value of lymphadenectomy in surgical resection of perihilar cholangiocarcinoma: a systematic review and meta-analysis.

Authors:  Lei Liang; Chao Li; Ming-Da Wang; Hao Xing; Yong-Kang Diao; Hang-Dong Jia; Wan Yee Lau; Timothy M Pawlik; Cheng-Wu Zhang; Feng Shen; Dong-Sheng Huang; Tian Yang
Journal:  Int J Clin Oncol       Date:  2021-06-23       Impact factor: 3.402

Review 10.  Prognostic Significance of Neutrophil to Lymphocyte Ratio in Oncologic Outcomes of Cholangiocarcinoma: A Meta-analysis.

Authors:  De-Wen Tan; Yan Fu; Qi Su; Ming-Jun Guan; Po Kong; Sheng-Qiang Wang; He-Ling Wang
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.